Helly Vernitsky

584 total citations
17 papers, 364 citations indexed

About

Helly Vernitsky is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Helly Vernitsky has authored 17 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Oncology and 4 papers in Hematology. Recurrent topics in Helly Vernitsky's work include CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (4 papers). Helly Vernitsky is often cited by papers focused on CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (4 papers). Helly Vernitsky collaborates with scholars based in Israel, United States and Slovakia. Helly Vernitsky's co-authors include Itamar Goldstein, Yoel Kloog, Gideon Rechavi, Yackov Berkun, Ninette Amariglio, Oded Rechavi, Jasmine Jacob‐Hirsch, Ilan Bank, Shomron Ben‐Horin and Yoram Cohen and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Helly Vernitsky

16 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helly Vernitsky Israel	8	222	103	93	42	38	17	364
Dmitrij Hristodorov Germany	13	225 1.0×	238 2.3×	100 1.1×	24 0.6×	25 0.7×	21	451
Danielle DiCara United Kingdom	10	97 0.4×	181 1.8×	106 1.1×	36 0.9×	15 0.4×	13	395
Francesca Gasparrini United Kingdom	15	352 1.6×	201 2.0×	74 0.8×	21 0.5×	18 0.5×	17	569
Ankit Mahendra India	9	122 0.5×	97 0.9×	129 1.4×	12 0.3×	67 1.8×	12	326
Dragan Grabulovski Switzerland	10	167 0.8×	235 2.3×	148 1.6×	21 0.5×	13 0.3×	21	443
James S. Wieler Canada	5	135 0.6×	236 2.3×	79 0.8×	16 0.4×	14 0.4×	5	376
Laura Cons Switzerland	7	185 0.8×	152 1.5×	79 0.8×	12 0.3×	50 1.3×	12	359
Eric Lynam United States	9	195 0.9×	231 2.2×	79 0.8×	23 0.5×	78 2.1×	11	520
Valeria Leuci Italy	14	347 1.6×	127 1.2×	405 4.4×	66 1.6×	28 0.7×	27	542
Hok Seon Kim United States	8	204 0.9×	207 2.0×	129 1.4×	20 0.5×	11 0.3×	11	488

Countries citing papers authored by Helly Vernitsky

Since Specialization

Citations

This map shows the geographic impact of Helly Vernitsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helly Vernitsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helly Vernitsky more than expected).

Fields of papers citing papers by Helly Vernitsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helly Vernitsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helly Vernitsky. The network helps show where Helly Vernitsky may publish in the future.

Co-authorship network of co-authors of Helly Vernitsky

This figure shows the co-authorship network connecting the top 25 collaborators of Helly Vernitsky. A scholar is included among the top collaborators of Helly Vernitsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helly Vernitsky. Helly Vernitsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Nováková, Michaela, Oscar Maglia, Angela Schumich, et al.. (2025). Flow-cytometric MRD detection in pediatric T-ALL: a multicenter AIEOP-BFM consensus-based guided standardized approach. Clinical Chemistry and Laboratory Medicine (CCLM). 63(7). 1419–1426. 1 indexed citations

Tierens, Anne, Liv Osnes, Sanna Siitonen, et al.. (2024). Presence of Leukemia-Related Basophils and Mast Cells with Atypical Immunophenotype during Induction Should Not be Interpreted As Measurable Residual Disease in Children with Acute Myeloid Leukemia with RUNX1::RUNX1T1. Blood. 144(Supplement 1). 2954–2954.

Heimer, Gali, Ben Pode‐Shakked, Dina Marek‐Yagel, et al.. (2024). Biallelic PIGM Coding Variant Causes Intractable Epilepsy and Intellectual Disability Without Thrombotic Events. Clinical Genetics. 107(2). 179–187. 1 indexed citations

Bielorai, Bella, et al.. (2023). Cerebral Spinal Fluid Parameters Following CD19-Targeted Therapies in Children and Young Adults. Journal of Pediatric Hematology/Oncology. 46(1). 29–32. 1 indexed citations

Itchaki, Gilad, Lior Rokach, Ohad Benjamini, et al.. (2021). Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia. Blood. 138(Supplement 1). 638–638. 3 indexed citations

Itzhaki, Orit, Elad Jacoby, Arnon Nagler, et al.. (2020). Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients. Journal for ImmunoTherapy of Cancer. 8(1). e000148–e000148. 37 indexed citations

Bielorai, Bella, Elad Jacoby, Nira Varda‐Bloom, et al.. (2019). Haploidentical hematopoietic stem cell transplantation with αβTCR+/CD19+ depletion in pediatric patients with malignant and non-malignant disorders. Bone Marrow Transplantation. 54(S2). 694–697. 5 indexed citations

Jacoby, Elad, Nira Varda‐Bloom, Gal Goldstein, et al.. (2017). Comparison of two cytoreductive regimens for αβ‐T‐cell‐depleted haploidentical HSCT in pediatric malignancies: Improved engraftment and outcome with TBI‐based regimen. Pediatric Blood & Cancer. 65(2). 9 indexed citations

Rechavi, Erez, Sarina Levy‐Mendelovich, Tali Stauber, et al.. (2016). Combined immunodeficiency in a patient with mosaic monosomy 21. Immunologic Research. 64(4). 841–847. 2 indexed citations

10.

Levy‐Mendelovich, Sarina, Erez Rechavi, Omar Abuzaitoun, et al.. (2015). Highlighting the problematic reliance on CD18 for diagnosing leukocyte adhesion deficiency type 1. Immunologic Research. 64(2). 476–482. 10 indexed citations

11.

Chetrit, David, Helly Vernitsky, Oded Rechavi, et al.. (2013). H-Ras transfers from B to T cells via tunneling nanotubes. Cell Death and Disease. 4(7). e726–e726. 44 indexed citations

12.

Vernitsky, Helly, Oded Rechavi, Michal J. Besser, et al.. (2012). Ras Oncoproteins Transfer from Melanoma Cells to T Cells and Modulate Their Effector Functions. The Journal of Immunology. 189(9). 4361–4370. 7 indexed citations

13.

Jacob‐Hirsch, Jasmine, Helly Vernitsky, Yackov Berkun, et al.. (2010). TNF Activates a NF-κB–Regulated Cellular Program in Human CD45RA– Regulatory T Cells that Modulates Their Suppressive Function. The Journal of Immunology. 184(7). 3570–3581. 115 indexed citations

14.

Rechavi, Oded, Yuan Fang, Helly Vernitsky, et al.. (2010). Trans-SILAC: sorting out the non-cell-autonomous proteome. Nature Methods. 7(11). 923–927. 29 indexed citations

15.

Jacob‐Hirsch, Jasmine, et al.. (2009). TNF/TNFR2 signaling in T regulatory (Treg) cells induces a distinctive NF-kB-dependent cellular program that modulate their suppressive capacity (89.27). The Journal of Immunology. 182(Supplement_1). 89.27–89.27. 1 indexed citations

16.

Vernitsky, Helly, Yoram Cohen, Dan Dominissini, et al.. (2008). Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells. International Immunology. 20(8). 1041–1055. 64 indexed citations

17.

Rechavi, Oded, Itamar Goldstein, Helly Vernitsky, Barak Rotblat, & Yoel Kloog. (2007). Intercellular Transfer of Oncogenic H-Ras at the Immunological Synapse. PLoS ONE. 2(11). e1204–e1204. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact